Regulations.gov document
Current Good Manufacturing Practice—Guidance for Human Drug Compounding Outsourcing…
Notice · FDA-2014-D-0779 · posted Dec 11, 2018
Key facts
| Document ID | FDA-2014-D-0779-0023 |
|---|---|
| Title | Current Good Manufacturing Practice—Guidance for Human Drug Compounding Outsourcing Facilities Under Section 503B of the FD&C Act; Draft Guidance for Industry; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2014-D-0779 |
| Posted | Dec 11, 2018 |
| Federal Register citation | 83 FR 63651 |
| FR document number | 2018-26724 |
| Comment period opens | Dec 11, 2018 |
| Comments due | Feb 12, 2019 |
| Effective date | Dec 11, 2018 |
At a glance
- 1–9 Pages
- No Open for comment
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: